AustinPx
AustinPx specializes in bioavailability enhancement and offers comprehensive formulation and process development services, including GMP manufacturing of oral dosage forms, from preclinical through Phase II clinical trials.
Services
AustinPx specializes in bioavailability enhancement, including the innovative KinetiSol technology platform. The company offers comprehensive services spanning preclinical through Phase II formulation, process development, and GMP manufacturing of oral dosage forms. Their solutions address poorly soluble molecules using a variety of technologies such as amorphous dispersions, particle size reduction, lipid delivery, complexation, fluid-bed processing, and hot-melt granulations. AustinPx's client-centric approach ensures flexibility, responsiveness, and consultative, unbiased solutions-driven development services.
KinetiSol Technology
AustinPx employs KinetiSol Technology, a next-generation amorphous dispersion platform designed to improve the bioavailability of poorly soluble molecules. This cutting-edge technology is an integral part of the company's suite of solutions, enabling more effective delivery of therapeutic compounds. KinetiSol Technology aligns with AustinPx's mission to enhance drug formulation and delivery.
Facilities and Location
AustinPx operates a state-of-the-art facility located in Georgetown, TX, approximately 30 miles from Austin Airport. The facility includes over 30,000 sq feet dedicated to development, manufacturing, warehousing, stability, and support. It houses GMP manufacturing suites designed to meet global regulatory requirements. The facility’s infrastructure supports the production of materials needed for preclinical through Phase II clinical trials.
Manufacturing Capabilities
AustinPx's manufacturing capabilities support the development and production of clinical trial materials for phases ranging from preclinical to Phase II. The company's GMP manufacturing suites adhere to global regulatory standards, ensuring the highest quality in oral dosage form production. AustinPx utilizes a variety of technologies, including particle size reduction and hot-melt granulations, to provide tailored solutions for enhancing drug bioavailability and solubility.
Client-Centric Approach
AustinPx emphasizes a client-centric approach in its contract development and manufacturing services. The company focuses on flexibility and responsiveness, providing consultative and unbiased solutions-driven development services. This approach ensures that each client receives customized support that aligns with their specific project needs and goals.